Copyright Reports & Markets. All rights reserved.

Global Human Papillomavirus (HPV) Testing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Pap Smear Test
      • 1.4.3 HPV DNA Test
    • 1.5 Market by Application
      • 1.5.1 Global Human Papillomavirus (HPV) Testing Market Share by Application (2014-2025)
      • 1.5.2 Diagnostic Centers
      • 1.5.3 Hospitals
      • 1.5.4 Clinic
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Human Papillomavirus (HPV) Testing Market Size
    • 2.2 Human Papillomavirus (HPV) Testing Growth Trends by Regions
      • 2.2.1 Human Papillomavirus (HPV) Testing Market Size by Regions (2014-2025)
      • 2.2.2 Human Papillomavirus (HPV) Testing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Human Papillomavirus (HPV) Testing Market Size by Manufacturers
      • 3.1.1 Global Human Papillomavirus (HPV) Testing Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Human Papillomavirus (HPV) Testing Key Players Head office and Area Served
    • 3.3 Key Players Human Papillomavirus (HPV) Testing Product/Solution/Service
    • 3.4 Date of Enter into Human Papillomavirus (HPV) Testing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Human Papillomavirus (HPV) Testing Market Size by Type (2014-2019)
    • 4.2 Global Human Papillomavirus (HPV) Testing Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Human Papillomavirus (HPV) Testing Market Size (2014-2019)
    • 5.2 Human Papillomavirus (HPV) Testing Key Players in United States
    • 5.3 United States Human Papillomavirus (HPV) Testing Market Size by Type
    • 5.4 United States Human Papillomavirus (HPV) Testing Market Size by Application

    6 Europe

    • 6.1 Europe Human Papillomavirus (HPV) Testing Market Size (2014-2019)
    • 6.2 Human Papillomavirus (HPV) Testing Key Players in Europe
    • 6.3 Europe Human Papillomavirus (HPV) Testing Market Size by Type
    • 6.4 Europe Human Papillomavirus (HPV) Testing Market Size by Application

    7 China

    • 7.1 China Human Papillomavirus (HPV) Testing Market Size (2014-2019)
    • 7.2 Human Papillomavirus (HPV) Testing Key Players in China
    • 7.3 China Human Papillomavirus (HPV) Testing Market Size by Type
    • 7.4 China Human Papillomavirus (HPV) Testing Market Size by Application

    8 Japan

    • 8.1 Japan Human Papillomavirus (HPV) Testing Market Size (2014-2019)
    • 8.2 Human Papillomavirus (HPV) Testing Key Players in Japan
    • 8.3 Japan Human Papillomavirus (HPV) Testing Market Size by Type
    • 8.4 Japan Human Papillomavirus (HPV) Testing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Human Papillomavirus (HPV) Testing Market Size (2014-2019)
    • 9.2 Human Papillomavirus (HPV) Testing Key Players in Southeast Asia
    • 9.3 Southeast Asia Human Papillomavirus (HPV) Testing Market Size by Type
    • 9.4 Southeast Asia Human Papillomavirus (HPV) Testing Market Size by Application

    10 India

    • 10.1 India Human Papillomavirus (HPV) Testing Market Size (2014-2019)
    • 10.2 Human Papillomavirus (HPV) Testing Key Players in India
    • 10.3 India Human Papillomavirus (HPV) Testing Market Size by Type
    • 10.4 India Human Papillomavirus (HPV) Testing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Human Papillomavirus (HPV) Testing Market Size (2014-2019)
    • 11.2 Human Papillomavirus (HPV) Testing Key Players in Central & South America
    • 11.3 Central & South America Human Papillomavirus (HPV) Testing Market Size by Type
    • 11.4 Central & South America Human Papillomavirus (HPV) Testing Market Size by Application

    12 International Players Profiles

    • 12.1 Roche
      • 12.1.1 Roche Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.1.4 Roche Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.1.5 Roche Recent Development
    • 12.2 Agilent Technologies
      • 12.2.1 Agilent Technologies Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.2.4 Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.2.5 Agilent Technologies Recent Development
    • 12.3 Becton, Dickinson and Company
      • 12.3.1 Becton, Dickinson and Company Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.3.4 Becton, Dickinson and Company Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.3.5 Becton, Dickinson and Company Recent Development
    • 12.4 Qiagen N.V.
      • 12.4.1 Qiagen N.V. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.4.4 Qiagen N.V. Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.4.5 Qiagen N.V. Recent Development
    • 12.5 Thermo Fisher Scientific Inc.
      • 12.5.1 Thermo Fisher Scientific Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.5.4 Thermo Fisher Scientific Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.5.5 Thermo Fisher Scientific Inc. Recent Development
    • 12.6 Abbott Laboratories
      • 12.6.1 Abbott Laboratories Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.6.4 Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.6.5 Abbott Laboratories Recent Development
    • 12.7 Hologic Inc.
      • 12.7.1 Hologic Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.7.4 Hologic Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.7.5 Hologic Inc. Recent Development
    • 12.8 Cepheid Inc.
      • 12.8.1 Cepheid Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.8.4 Cepheid Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.8.5 Cepheid Inc. Recent Development
    • 12.9 Seegene Inc.
      • 12.9.1 Seegene Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.9.4 Seegene Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.9.5 Seegene Inc. Recent Development
    • 12.10 Takara Bio Inc.
      • 12.10.1 Takara Bio Inc. Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Human Papillomavirus (HPV) Testing Introduction
      • 12.10.4 Takara Bio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2014-2019)
      • 12.10.5 Takara Bio Inc. Recent Development
    • 12.11 DaAn Gene of Sun Yat-Sen University
    • 12.12 Promega Corporation
    • 12.13 Greiner Bio-One International GmbH (Greiner Holding AG)
    • 12.14 Enzo Biochem Inc.
    • 12.15 Norgen Biotek
    • 12.16 DiagCor Bioscience Inc Ltd
    • 12.17 Hybribio Limited
    • 12.18 Zytovision GmbH
    • 12.19 Arbor Vita Corporation
    • 12.20 Medical & Biological Laboratories Co., Ltd
    • 12.21 Fujirebio Diagnostics

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      HPV infections can infect the genital areas of men including the skin on and around the penis or anus. These infections can also be spread to the mouth and the throat. Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, penile cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men. The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men.
      In 2018, the global Human Papillomavirus (HPV) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Human Papillomavirus (HPV) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Papillomavirus (HPV) Testing development in United States, Europe and China.

      The key players covered in this study
      Roche
      Agilent Technologies 
      Becton, Dickinson and Company 
      Qiagen N.V. 
      Thermo Fisher Scientific Inc. 
      Abbott Laboratories 
      Hologic Inc. 
      Cepheid Inc. 
      Seegene Inc. 
      Takara Bio Inc. 
      DaAn Gene of Sun Yat-Sen University 
      Promega Corporation 
      Greiner Bio-One International GmbH (Greiner Holding AG) 
      Enzo Biochem Inc. 
      Norgen Biotek 
      DiagCor Bioscience Inc Ltd 
      Hybribio Limited 
      Zytovision GmbH 
      Arbor Vita Corporation 
      Medical & Biological Laboratories Co., Ltd 
      Fujirebio Diagnostics

      Market segment by Type, the product can be split into
      Pap Smear Test
      HPV DNA Test

      Market segment by Application, split into
      Diagnostic Centers
      Hospitals
      Clinic

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Human Papillomavirus (HPV) Testing status, future forecast, growth opportunity, key market and key players.
      To present the Human Papillomavirus (HPV) Testing development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Human Papillomavirus (HPV) Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now